Some independent practices utilize clinical pathways to mange complex regimens, but lack of education and cost concerns may limit practices' use of clinical pathways, said Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders.
Some independent practices utilize clinical pathways to mange complex regimens, but lack of education and cost concerns may limit practices' use of clinical pathways, said Ray Page, DO, PhD, president and director of research at The Center for Cancer and Blood Disorders.
Transcript:
What are the challenges and benefits of using clinical pathways for an independent practice?
I think independent practices have a great opportunity to use those clinical pathways in a way to create efficiencies within the practice in order to better manage complex chemotherapy regimens, as well as to manage much of the complex symptoms associated with with cancer patients actively on therapy. I think a lot of practices have not implemented pathways yet, partly because of just lack of education or exposure. I think some practices feel that they have their own methodologies in place just by doing it on their own. Then sometimes there's the cost of a pathway system that comes into play. As far as Quality Cancer Care Alliance (QCCA) goes, as a group and through group purchasing, we've been able to create what I think are financially advantageous opportunities to be able to run clinical pathways within independent practice groups.
How does participating in Quality Cancer Care Alliance foster productive use of clinical pathways?
Clinical pathways is a core element, in my opinion, on being able to provide value-based care. That's one of the major objectives of QCCA as a network of strong independent practices in order to optimize value-based delivery of care. QCCA feels strongly that the implementation of clinical pathways and symptom management pathways is part of the stuff that we need in order to achieve value-based delivery of care.
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Strategies for Improving Patient Access to Dermatology Care
March 22nd 2025Elizabeth Jones, MD, FAAD, highlights the persistent issue of insurance companies favoring expensive, newer medications over equally effective generics in dermatology, emphasizing the time-consuming prior authorization process and advocating for patient partnerships and systemic improvements.
Read More
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More